Journal of Peking University(Health Sciences) ›› 2019, Vol. 51 ›› Issue (1): 165-170. doi: 10.19723/j.issn.1671-167X.2019.01.028
Previous Articles Next Articles
Yang ZHANG1,Ji-xin ZHANG2,Jian SHI3,Nan YU1,Zhen-fang YUAN1,Gui-zhi LU1,Ying GAO1,△(),Yan-ming GAO1,Xiao-hui GUO1
CLC Number:
[1] |
Stein SA, Wartofsky L . Primary thyroid lymphoma: a clinical review[J]. J Clin Endocrinol Metab, 2013,98(8):3131-3138.
doi: 10.1210/jc.2013-1428 pmid: 23714679 |
[2] |
Sarinah B, Hisham AN . Primary lymphoma of the thyroid: diagnostic and therapeutic considerations[J]. Asian J Surg, 2010,33(1):20-24.
doi: 10.1016/S1015-9584(10)60004-8 pmid: 20497878 |
[3] |
Onal C, Li YX, Miller RC , et al. Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study[J]. Ann Oncol, 2011,22(1):156-164.
doi: 10.1093/annonc/mdq310 pmid: 20587509 |
[4] |
Mack LA, Pasieka JL . An evidence-based approach to the treatment of thyroid lymphoma[J]. World J Surg, 2007,31(5):978-986.
doi: 10.1007/s00268-005-0768-z |
[5] |
Alzouebi M, Goepel JR, Horsman JM , et al. Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre[J]. Int J Oncol, 2012,40(6):2075-2080.
doi: 10.3892/ijo.2012.1387 pmid: 22367111 |
[6] |
Sakorafas GH, Kokkoris P, Farley DR . Primary thyroid lymphoma (correction of lympoma): diagnostic and therapeutic dilemmas[J]. Surg Oncol, 2010,19(4):e124-e129.
doi: 10.1016/j.suronc.2010.06.002 |
[7] |
李昌幼, 罗佐杰 . 原发性甲状腺淋巴瘤的发病机制及诊治现状[J]. 实用医学杂志, 2013,2(3):341-342.
doi: 10.3969/j.issn.1006-5725.2013.03.001 |
[8] |
Holm LE, Blomgren H, Lowhagen T . Cancer risks in patients with chronic lymphocytic thyroiditis[J]. N Engl J Med, 1985,312(10):601-604.
doi: 10.1056/NEJM198503073121001 |
[9] |
Noureldine SI, Tufano RP . Association of Hashimoto’s thyroiditis and thyroid cancer[J]. Curr Opin Oncol, 2015,27(1):21-25.
doi: 10.1097/CCO.0000000000000150 pmid: 25390557 |
[10] | 朱坚, 费健 . 原发性甲状腺淋巴瘤的诊断和治疗分析[J]. 外科理论与实践, 2013,18(2):156-158. |
[11] | 谢婧, 邓先兆, 樊友本 , 等. 原发性甲状腺淋巴瘤疗效分析[J]. 中国普外基础与临床杂志, 2014,21(9):1097-1101. |
[12] |
Ota H, Ito Y, Matsuzuka F , et al. Usefulness of ultrasonography for diagnosis of malignant lymphoma of the thyroid[J]. Thyroid, 2006,16(10):983-987.
doi: 10.1089/thy.2006.16.983 pmid: 17042683 |
[13] |
杨光旭, 彭格红 . 原发性甲状腺淋巴瘤超声表现与病理对比分析[J]. 现代医药卫生, 2017,33(4):566-567.
doi: 10.3969/j.issn.1009-5519.2017.04.034 |
[14] |
Yang L, Wang A, Zhang Y , et al. 12 cases of primary thyroid lymphoma in China[J]. J Endocrinol Invest, 2015,38(7):739-744.
doi: 10.1007/s40618-015-0250-6 pmid: 25736543 |
[15] |
骆惊涛, 魏玺, 张仑 . 原发性甲状腺淋巴瘤的超声表现病理及其他影像学特征分析[J]. 中国肿瘤临床, 2014,41(2):123-126.
doi: 10.3969/j.issn.1000-8179.20131453 |
[16] |
彭晓琼, 蒲大容, 涂波 , 等. 原发性甲状腺恶性淋巴瘤的声像图特征及误诊分析[J]. 重庆医学, 2015,44(16):2260-2262.
doi: 10.3969/j.issn.1671-8348.2015.16.037 |
[17] | 杨盼, 孙映荷, 马步云 , 等. 原发性甲状腺非霍奇金淋巴瘤的超声征象分析[J]. 中国普外基础与临床杂志, 2014,21(9):1092-1096. |
[18] | 张雨涵, 龚洪翰, 张宁 , 等. 原发甲状腺淋巴瘤的CT诊断与鉴别诊断[J]. 实用放射学杂志, 2014,30(7):1238-1240. |
[19] |
Basu S, Li G, Bural G , et al. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility[J]. Acta Radiol, 2009,50(2):201-204.
doi: 10.1080/02841850802620689 pmid: 19089692 |
[20] |
Derringer GA, Thompson LD, Frommelt RA , et al. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases[J]. Am J Surg Pathol, 2000,24(5):623-639.
doi: 10.1097/00000478-200005000-00001 |
[21] |
张秉均, 薛勇敢, 刘洪军 , 等. 20例原发性甲状腺淋巴瘤的临床分析[J]. 解放军医学院学报, 2015,36(5):419-423.
doi: 10.3969/j.issn.2095-5227.2015.05.004 |
[22] | 夏青萍, 卫骆云 . 原发性甲状腺恶性淋巴瘤合并桥本氏甲状腺炎11例诊治分析[J]. 浙江实用医学, 2015,20(5):335-337. |
[23] |
Sangalli G, Serio G, Zampatti C , et al. Fine needle aspirationcytology of primary lymphoma of the thyroid: a report of 17 cases[J]. Cytopathology, 2001,12(4):257-263.
doi: 10.1046/j.1365-2303.2001.00338.x pmid: 11488875 |
[24] |
朱庆莉, 姜玉新, 李文波 , 等. 超声引导组织活检对原发性甲状腺淋巴瘤的诊断价值[J]. 协和医学杂志, 2014,5(1):3-7.
doi: 10.3969/j.issn.1674-9081.2014.01.002 |
[25] |
Matsuzuka F, Miyauchi A, Katayama S , et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based onour experience of 119 cases[J]. Thyroid, 1993,3(2):93-99.
doi: 10.1089/thy.1993.3.93 |
[26] |
Wang SA, Rahemtullah A, Faquin WC , et al. Hodgkin’s lymphoma of the thyroid: a clinicopathologic study of five cases andreview of the literature[J]. Mod Pathol, 2005,18(12):1577-1584.
doi: 10.1038/modpathol.3800501 pmid: 16258502 |
[27] |
Pyke CM, Grant CS, Habermann TM , et al. Non-Hodgkin’s lymphoma of the thyroid: is more than biopsynecessary?[J]. World J Surg, 1992,16(4):604-609.
doi: 10.1007/BF02067333 pmid: 1413831 |
[28] |
Molina A . A decade of rituximab: improving survival outcomes in non-Hodgkin’s lymphoma[J]. Annu Rev Med, 2008,59:237-250.
doi: 10.1146/annurev.med.59.060906.220345 pmid: 18186705 |
[29] |
Penney SE, Homer JJ . Thyroid lymphoma: acute presentation and long-termoutcome[J]. J Laryngol Otol, 2011,125(12):1256-1262.
doi: 10.1017/S0022215111001812 pmid: 21835073 |
[30] |
Belal AA, Allam A, Kandil A , et al. Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma[J]. Am J Clin Oncol, 2001,24(3):299-305.
doi: 10.1097/00000421-200106000-00019 |
[1] | Yun-fei SHI,Hao-jie WANG,Wei-ping LIU,Lan MI,Meng-ping LONG,Yan-fei LIU,Yu-mei LAI,Li-xin ZHOU,Xin-ting DIAO,Xiang-hong LI. Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 521-529. |
[2] | Qian SU,Xin PENG,Chuan-xiang ZHOU,Guang-yan YU. Clinicopathological characteristics and prognosis of non-Hodgkin lymphoma in oral and maxillofacial regions: An analysis of 369 cases [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 13-21. |
[3] | LIAO Xu-he,WANG Rong-fu,LIU Meng,CHEN Xue-qi,XIONG Yan,NONG Lin,YIN Lei,ZHANG Bing-ye,DU Yu-jing. Semiquantitative parameters of 18F-FDG PET/CT, gene mutation states of epidermal growth factor receptor and anaplastic lymphoma kinase in prognosis evaluation of patients with lung adenocarcinoma [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 246-254. |
[4] | CHI Yan-ting,ZHANG Yan-ping,ZHANG Qiu-lu,LIU Cui-ling,LI bin-bin. Clinicopathological analysis of mucosa associated lymphoid tissue lymphoma secondary to Sjögren’s syndrome in salivary gland [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 40-45. |
[5] | Gong CHENG,Xia ZHANG,Fei YANG,Jia-yu CHENG,Yan-ying LIU. Angioimmunoblastic T-cell lymphoma with fever, arthritis and skin pigmentation: A case report [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1150-1152. |
[6] | Yan TIAN,Jun ZHU. Relationship between p53 rs1625895 polymorphism and prognosis in diffuse large B-cell lymphoma [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 791-796. |
[7] | Qian SU,Xin PENG,Chuan-xiang ZHOU,Guang-yan YU. Clinicopathological features and possible prognostic factors in parotid lymphomas [J]. Journal of Peking University(Health Sciences), 2019, 51(1): 35-42. |
[8] | LIU Ai-chun, CHEN Yong, JIA Jin-song, GAO Song-yuan, LIU Yan-ying. Non-Hodgkin’s lymphoma mimicking Mikulicz disease: a case report [J]. Journal of Peking University(Health Sciences), 2016, 48(6): 1074-1076. |
[9] | WAN Wenli, WANG Jing, ZHU Mingxia,ZHANG Wei, KE Xiaoyan. Retrospective analyses of CHOPE plus L-asparaginase regimen in treatment of T-cell lymphoma [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 841-845. |
[10] | ZHANG Meng-Xue-1, PEI Fei-1△, WANG Tian-Li-2, HAN Xiang-3, YOU Jiang-Feng-1, ZOU Peng-Cheng-1, WANG Yue-Qi-1, LI Xu-Wen-1, LIU Xin-1, ZHONG Gao-Gao-1, LIU Yan-1, WANG Yu-Xiang-1, WANG Hua-1, ZHANG Bo-1. Anaplastic lymphoma kinase fusion gene expression, clinical pathological characteristics and prognosis in 95 Chinese patients with non-small cell lung cancer [J]. Journal of Peking University(Health Sciences), 2014, 46(4): 582-588. |
[11] | FU Zhi-Ying, ZHU Jun, SONG Yu-Qin, LIU Wei-Ping, JI Xin-Qiang, ZHAN Si-Yan. Prognostic analysis of 525 Chinese patients with diffuse large B cell lymphoma [J]. Journal of Peking University(Health Sciences), 2014, 46(3): 405-411. |
|